Risks with danazol in the acquired immunodeficiency syndrome.

C. Metroka,Anne Moore,Joseph Sonnabend,Susanna Cunningham-Rundles
DOI: https://doi.org/10.7326/0003-4819-101-4-564_2
IF: 39.2
1984-10-01
Annals of Internal Medicine
Abstract:Excerpt To the editor: Recently, danazol (Danocrine; Winthrop Laboratories, New York, New York) has been reported to decrease the need for transfusions of plasma products in persons with classic he...
What problem does this paper attempt to address?